Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pacira BioSciences, Inc. Director's Dealing 2021

Jun 8, 2021

32125_dirs_2021-06-08_2b811b10-f69e-4aa9-aec6-48992a5e60da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-06-04

Reporting Person: LARANJEIRA CHARLES ANTHONY (Chief Technical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-04 Common Stock S 2117 $61.037 Disposed 18681 Direct

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2: Includes 2 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020.